Scroll Top
Gain Therapeutics Inc.

Gain Therapeutics Doses First Patient in Phase 1b Parkinson’s Trial

Clinical Trial Vanguard

March 17, 2025

Gain Therapeutics Doses First Patient in Phase 1b Parkinson’s Trial

Latest Articles

Clear Filters
May 14, 2025
Other news to note for May 14, 2025
https://www.bioworld.com/articles/720169-other-news-to-note-for-may-14-2025?v=preview
Read More
May 12, 2025
Webinar: The opportunities in neuroscience drug discovery
https://www.ddw-online.com/webinar-the-challenges-and-opportunities-in-neuroscience-drug-discovery-34758-202505/
Read More
March 19, 2025
First Parkinson’s patient dosed in GT-02287 clinical trial
https://parkinsonsnewstoday.com/news/first-parkinsons-patient-dosed-clinical-trial-gt-02287/
Read More